What is restrictive lung disease? It occur when lung tissue becomes fibrotic and firm which reduces the total lung capacity.

Find more videos at http://osms.it/more.

Join over 3 million current & future clinicians who learn by Osmosis, and over 130 universities around the world who partner with us to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you to succeed in school, on board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. If you’re interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo.

Follow us on social:
Facebook: http://osms.it/facebook
Twitter: http://osms.it/twitter
Instagram for med: http://osms.it/instagram
Instagram for nursing: https://osms.it/ignursing
Linkedin: https://osms.it/linkedin

Our Vision: Everyone who cares for someone will learn by Osmosis.
Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission

Medical disclaimer: Knowledge Diffusion Inc (DBA Osmosis) does not provide medical advice. Osmosis and the content available on Osmosis’s properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed health care provider. Always seek the advice of a physician or other qualified healthcare provider with any questions you have regarding a medical condition. © 2023 Elsevier. All rights reserved.
Video Rating: / 5

Share this page:

Where do I get my information from: http://armandoh.org/resource

“Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.

Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.

The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes.”

Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7

Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan

Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl

You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia

Share this page:

An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
Video Rating: / 5

Share this page: